Strong and nonspecific synergistic antibacterial efficiency of antibiotics combined with silver nanoparticles at very low concentrations showing no cytotoxic effect

Molecules

Volumn 21, Issue 1, 2016, Pages

  Panácek, Aleš ^a   Smékalová, Monika ^a   Kilianová, Martina ^a   Prucek, Robert ^a   Bogdanová, Katěrina ^a   Věcěrová, Renata ^a   Kolár, Milan ^a   Havrdová, Markéta ^a   Płaza, Grazyna Anna ^b   Chojniak, Joanna ^b   Zbǒril, Radek ^a   Kvítek, Libor ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR ECOLOGY OF INDUSTRIAL AREAS   (Poland)

Author keywords

Antibacterial; Antibiotics; Cytotoxicity; Resistant bacteria; Silver nanoparticle; Synergism

Indexed keywords

ANTIINFECTIVE AGENT; METAL NANOPARTICLE; SILVER;

ANIMAL; ANTIBIOTIC RESISTANCE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; DRUG POTENTIATION; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TEST; MOUSE; NIH 3T3 CELL LINE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; ESCHERICHIA COLI; METAL NANOPARTICLES; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NIH 3T3 CELLS; PSEUDOMONAS AERUGINOSA; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 85000605849     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules21010026     Document Type: Article

References (71)

1. Walsh, T.R.; Toleman, M.A. The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. J. Antimicrob. Chemother. 2012, 67, 1-3. [Cross Ref] [Pub Med].
2. Theuretzbacher, U. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. Int. J. Antimicrob. Agents 2012, 39, 295-299. [Cross Ref] [Pub Med].
3. Barbosa, T.M.; Levy, S.B. The impact of antibiotic use on resistance development and persistence. Drug Resist. Update 2000, 3, 303-311. [Cross Ref] [Pub Med].
4. Mokaddas, E.; Rotimi, V.O.; Sanyal, S.C. In vitro activity of piperacillin/tazobactam versus other broad-spectrum antibiotics against nosocomial gram-negative pathogens isolated from burn patients. J. Chemother. 1998, 10, 208-214. [Cross Ref] [Pub Med].
5. Retsema, J.A.; English, A.R.; Girard, A.; Lynch, J.E.; Anderson, M.; Brennan, L.; Cimochowski, C.; Faiella, J.; Norcia, W.; Sawyer, P. Sulbactam ampicillin-In vitro spectrum, potency, and activity in models of acute infection. Rev. Infect. Dis. 1986, 8, S528-S534. [Cross Ref] [Pub Med].
6. Todd, P.A.; Benfield, P. Amoxicillin clavulanic acid-An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1990, 39, 264-307. [Cross Ref] [Pub Med].
7. Antimicrobial Resistance Surveillance in Europe 2013. Annual Report of the European Antimicrobial Resistance Surveillance Network (Ears-Net). 978-92-9193-603-8. Stockholm, 2014. Avalaible online: http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2013.pdf (accessed on 17 November 2014).
8. Li, W.R.; Xie, X.B.; Shi, Q.S.; Duan, S.S.; Ouyang, Y.S.; Chen, Y.B. Antibacterial effect of silver nanoparticles on staphylococcus aureus. Biometals 2011, 24, 135-141. [Cross Ref] [Pub Med].
9. Li, W.R.; Xie, X.B.; Shi, Q.S.; Zeng, H.Y.; Ou-Yang, Y.S.; Chen, Y.B. Antibacterial activity and mechanism of silver nanoparticles on escherichia coli. Appl. Microbiol. Biot. 2010, 85, 1115-1122. [Cross Ref] [Pub Med].
10. Cui, L.; Chen, P.Y.; Chen, S.D.; Yuan, Z.H.; Yu, C.P.; Ren, B.; Zhang, K.S. In situ study of the antibacterial activity and mechanism of action of silver nanoparticles by surface-enhanced raman spectroscopy. Anal. Chem. 2013, 85, 5436-5443. [Cross Ref] [Pub Med].
11. Lara, H.H.; Ayala-Nunez, N.V.; Turrent, L.D.I.; Padilla, C.R. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J. Microb. Biot. 2010, 26, 615-621. [Cross Ref].
12. Lok, C.N.; Ho, C.M.; Chen, R.; He, Q.Y.; Yu, W.Y.; Sun, H.Z.; Tam, P.K.H.; Chiu, J.F.; Che, C.M. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res. 2006, 5, 916-924. [Cross Ref] [Pub Med].
13. Morones, J.R.; Elechiguerra, J.L.; Camacho, A.; Holt, K.; Kouri, J.B.; Ramirez, J.T.; Yacaman, M.J. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16, 2346-2353. [Cross Ref] [Pub Med].
14. Sondi, I.; Salopek-Sondi, B. Silver nanoparticles as antimicrobial agent: A case study on e-coli as a model for gram-negative bacteria. J. Colloid Interf. Sci. 2004, 275, 177-182. [Cross Ref] [Pub Med].
15. Choi, O.; Hu, Z.Q. Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ. Sci. Technol. 2008, 42, 4583-4588. [Cross Ref] [Pub Med].
16. Kim, J.S.; Kuk, E.; Yu, K.N.; Kim, J.H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.Y.; et al. Antimicrobial effects of silver nanoparticles. Nanomed. Nanotechnol. 2007, 3, 95-101. [Cross Ref] [Pub Med].
17. Xu, H.Y.; Qu, F.; Xu, H.; Lai, W.H.; Wang, Y.A.; Aguilar, Z.P.; Wei, H. Role of reactive oxygen species in the antibacterial mechanism of silver nanoparticles on escherichia coli o157:H7. Biometals 2012, 25, 45-53. [Cross Ref] [Pub Med].
18. Cabiscol, E.; Tamarit, J.; Ros, J. Oxidative stress in bacteria and protein damage by reactive oxygen species. Int. Microbiol. 2000, 3, 3-8. [Pub Med].
19. Kvitek, L.; Panacek, A.; Soukupova, J.; Kolar, M.; Vecerova, R.; Prucek, R.; Holecova, M.; Zboril, R. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (nps). J. Phys. Chem. C 2008, 112, 5825-5834. [Cross Ref].
20. Panacek, A.; Kolar, M.; Vecerova, R.; Prucek, R.; Soukupova, J.; Krystof, V.; Hamal, P.; Zboril, R.; Kvitek, L. Antifungal activity of silver nanoparticles against candida spp. Biomaterials 2009, 30, 6333-6340. [Cross Ref] [Pub Med].
21. Panacek, A.; Kvitek, L.; Prucek, R.; Kolar, M.; Vecerova, R.; Pizurova, N.; Sharma, V.K.; Nevecna, T.; Zboril, R. Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity. J. Phys. Chem. B 2006, 110, 16248-16253. [Cross Ref] [Pub Med].
22. Shrivastava, S.; Bera, T.; Roy, A.; Singh, G.; Ramachandrarao, P.; Dash, D. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 2007, 18, 225103. [Cross Ref].
23. Silver, S. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 2003, 27, 341-353. [Cross Ref].
24. Silver, S.; Phung, L.T.; Silver, G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. J. Ind. Microbiol. Biotechnol. 2006, 33, 627-634. [Cross Ref] [Pub Med].
25. Kremer, A.N.; Hoffmann, H. Subtractive hybridization yields a silver resistance determinant unique to nosocomial pathogens in the enterobacter cloacae complex. J. Clin. Microbiol. 2012, 50, 3249-3257. [Cross Ref] [Pub Med].
26. Haefeli, C.; Franklin, C.; Hardy, K. Plasmid-determined silver resistance in pseudomonas-stutzeri isolated from a silver mine. J. Bacteriol. 1984, 158, 389-392. [Pub Med].
27. Gupta, A.; Matsui, K.; Lo, J.F.; Silver, S. Molecular basis for resistance to silver cations in salmonella. Nat. Med. 1999, 5, 183-188. [Cross Ref] [Pub Med].
28. Li, X.Z.; Nikaido, H.;Williams, K.E. Silver-resistant mutants of escherichia coli display active efflux of ag+ and are deficient in porins. J. Bacteriol. 1997, 179, 6127-6132. [Pub Med].
29. Nies, D.H. Efflux-mediated heavy metal resistance in prokaryotes. FEMS Microbiol. Rev. 2003, 27, 313-339. [Cross Ref].
30. Potara, M.; Jakab, E.; Damert, A.; Popescu, O.; Canpean, V.; Astilean, S. Synergistic antibacterial activity of chitosan-silver nanocomposites on staphylococcus aureus. Nanotechnology 2011, 22, 135101. [Cross Ref] [Pub Med].
31. Vertelov, G.K.; Krutyakov, Y.A.; Efremenkova, O.V.; Olenin, A.Y.; Lisichkin, G.V. A versatile synthesis of highly bactericidal myramistin (r) stabilized silver nanoparticles. Nanotechnology 2008, 19. [Cross Ref] [Pub Med].
32. Ammons, M.C.B.; Ward, L.S.; James, G.A. Anti-bio film efficacy of a lacto ferrin/xylitol wound hydrogel used in combination with silver wound dressings. Int. Wound. J. 2011, 8, 268-273. [Cross Ref] [Pub Med].
33. Ruden, S.; Hilpert, K.; Berditsch, M.; Wadhwani, P.; Ulrich, A.S. Synergistic interaction between silver nanoparticles and membrane-permeabilizing antimicrobial peptides. Antimicrob. Agents Chemother. 2009, 53, 3538-3540. [Cross Ref] [Pub Med].
34. Birla, S.S.; Tiwari, V.V.; Gade, A.K.; Ingle, A.P.; Yadav, A.P.; Rai, M.K. Fabrication of silver nanoparticles by phoma glomerata and its combined effect against escherichia coli, pseudomonas aeruginosa and staphylococcus aureus. Lett. Appl. Microbiol. 2009, 48, 173-179. [Cross Ref] [Pub Med].
35. Fayaz, A.M.; Balaji, K.; Girilal, M.; Yadav, R.; Kalaichelvan, P.T.; Venketesan, R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: A study against gram-positive and gram-negative bacteria. Nanomed. Nanotechnol. 2010, 6, 103-109. [Cross Ref] [Pub Med].
36. Ghosh, S.; Patil, S.; Ahire, M.; Kitture, R.; Kale, S.; Pardesi, K.; Cameotra, S.S.; Bellare, J.; Dhavale, D.D.; Jabgunde, A.; et al. Synthesis of silver nanoparticles using dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents. Int. J. Nanomed. 2012, 7, 483-496.
37. Muhsin, T.M.; Hachim, A.K. Mycosynthesis and characterization of silver nanoparticles and their activity against some human pathogenic bacteria. World J. Microbiol. Biotechnol. 2014, 30, 2081-2090. [Cross Ref] [Pub Med].
38. Naqvi, S.Z.H.; Kiran, U.; Ali, M.I.; Jamal, A.; Hameed, A.; Ahmed, S.; Ali, N. Combined efficacy of biologically synthesized silver nano particles and different antibiotics against multidrug-resistant bacteria. Int. J. Nanomed. 2013, 8, 187-195. [Cross Ref] [Pub Med].
39. Sathiyanarayanan, G.; Kiran, G.S.; Selvin, J. Synthesis of silver nanoparticles by polysaccharide bioflocculant produced from marine bacillus subtilis msbn17. Colloid. Surf. B 2013, 102, 13-20. [Cross Ref] [Pub Med].
40. Shahverdi, A.R.; Fakhimi, A.; Shahverdi, H.R.; Minaian, S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomed. Nanotechnol. 2007, 3, 168-171. [Cross Ref] [Pub Med].
41. Hwang, I.S.; Hwang, J.H.; Choi, H.; Kim, K.J.; Lee, D.G. Synergistic effects between silver nanoparticles and antibiotics and the mechanisms involved. J. Med. Microbiol. 2012, 61, 1719-1726. [Cross Ref] [Pub Med].
42. Li, P.; Li, J.; Wu, C.Z.; Wu, Q.S.; Li, J. Synergistic antibacterial effects of beta-lactam antibiotic combined with silver nanoparticles. Nanotechnology 2005, 16, 1912-1917. [CrossRef].
43. Markowska, K.; Grudniak, A.M.; Krawczyk, K.;Wrobel, I.;Wolska, K.I. Modulation of antibiotic resistance and induction of a stress response in pseudomonas aeruginosa by silver nanoparticles. J. Med. Microbiol. 2014, 63, 849-854. [Cross Ref] [Pub Med].
44. Singh, R.; Wagh, P.; Wadhwani, S.; Gaidhani, S.; Kumbhar, A.; Bellare, J.; Chopade, B.A. Synthesis, optimization, and characterization of silver nanoparticles from acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics. Int. J. Nanomed. 2013, 8, 4277-4289.
45. Brown, A.N.; Smith, K.; Samuels, T.A.; Lu, J.R.; Obare, S.O.; Scott, M.E. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of pseudomonas aeruginosa and enterobacter aerogenes and methicillin-resistant staphylococcus aureus. Appl. Environ. Microbiol. 2012, 78, 2768-2774. [Cross Ref] [Pub Med].
46. Kvitek, L.; Prucek, R.; Panacek, A.; Novotny, R.; Hrbac, J.; Zboril, R. The influence of complexing agent concentration on particle size in the process of sers active silver colloid synthesis. J. Mater. Chem. 2005, 15, 1099-1105. [Cross Ref].
47. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of Mics and Zone Diameters. Version 5.0. Avalaible online: http://www.eucast.org/clinical-breakpoints/(accessed on 1 January 2015).
48. Krishnaraj, C.; Jagan, E.G.; Rajasekar, S.; Selvakumar, P.; Kalaichelvan, P.T.; Mohan, N. Synthesis of silver nanoparticles using acalypha indica leaf extracts and its antibacterial activity against water borne pathogens. Colloid. Surf. B 2010, 76, 50-56. [Cross Ref] [Pub Med].
49. Zhang, M.; Wang, P.; Sun, H.; Wang, Z. Superhydrophobic Surface with Hierarchical Architecture and Bimetallic Composition for Enhanced Antibacterial Activity. ACS Appl. Mater. Interfaces 2014, 6, 22108-22115. [Cross Ref] [Pub Med].
50. Agnihotri, S.; Mukherji, S.; Mukherji, S. Size-controlled silver nanoparticles synthesized over the range 5-100 nm using the same protocol and their antibacterial efficacy. RSC Adv. 2014, 4, 3974-3983. [CrossRef].
51. El-Zahry, M.R.; Mahmoud, A.; Refaat, I.H.; Mohamed, H.A.; Bohlmann, H.; Lendl, B. Antibacterial effect of various shapes of silver nanoparticles monitored by sers. Talanta 2015, 138, 183-189. [Cross Ref] [Pub Med].
52. Pal, S.; Tak, Y.K.; Song, J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle A study of the gram-negative bacterium escherichia coli. Appl. Environ. Microbiol. 2007, 73, 1712-1720. [Cross Ref] [Pub Med].
53. Singh, S.; Bharti, A.; Meena, V.K. Green synthesis of multi-shaped silver nanoparticles: Optical, morphological and antibacterial properties. J. Mater. Sci. Mater. Electron. 2015, 26, 3638-3648. [CrossRef].
54. Habash, M.B.; Park, A.J.; Vis, E.C.; Harris, R.J.; Khursigara, C.M. Synergy of silver nanoparticles and aztreonam against pseudomonas aeruginosa pao1 biofilms. Antimicrob. Agents Chemother. 2014, 58, 5818-5830. [CrossRef] [PubMed].
55. Kareem, P.A.; Alsammak, E.G. The Effect of Silver and Zinc Oxide Nanoparticles on Multi Drug Resistance Staphylococcus aureus. Int. J. Adv. Res. 2014, 12, 405-417.
56. Kora, A.J.; Rastogi, L. Enhancement of antibacterial activity of capped silver nanoparticles in combination with antibiotics, on model gram-negative and gram-positive bacteria. Bioinorg. Chem. Appl. 2013, 2013, 871097. [Cross Ref] [Pub Med].
57. Krajewski, S.; Prucek, R.; Panacek, A.; Avci-Adali, M.; Nolte, A.; Straub, A.; Zboril, R.; Wendel, H.P.; Kvitek, L. Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified chandler-loop in vitro assay on human blood. Acta Biomater. 2013, 9, 7460-7468. [Cross Ref] [Pub Med].
58. Kvitek, L.; Vanickova, M.; Panacek, A.; Soukupova, J.; Dittrich, M.; Valentova, E.; Prucek, R.; Bancirova, M.; Milde, D.; Zboril, R. Initial study on the toxicity of silver nanoparticles (nps) against paramecium caudatum. J. Phys. Chem. C 2009, 113, 4296-4300. [Cross Ref].
59. Panacek, A.; Prucek, R.; Safarova, D.; Dittrich, M.; Richtrova, J.; Benickova, K.; Zboril, R.; Kvitek, L. Acute and chronic toxicity effects of silver nanoparticles (nps) on drosophila melanogaster. Environ. Sci. Technol. 2011, 45, 4974-4979. [Cross Ref] [Pub Med].
60. Richter, A.P.; Brown, J.S.; Bharti, B.; Wang, A.; Gangwal, S.; Houck, K.; Hubal, E.A.C.; Paunov, V.N.; Stoyanov, S.D.; Velev, O.D. An environmentally benign antimicrobial nanoparticle based on a silver-infused lignin core. Nat. Nanotechnol. 2015, 10, 817-823. [Cross Ref] [Pub Med].
61. Munger, M.A.; Radwanski, P.; Hadlock, G.C.; Stoddard, G.; Shaaban, A.; Falconer, J.; Grainger, D.W.; Deering-Rice, C.E. In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomed. Nanotechnol. 2014, 10, 1-9. [Cross Ref] [Pub Med].
62. Kim, Y.S.; Kim, J.S.; Cho, H.S.; Rha, D.S.; Kim, J.M.; Park, J.D.; Choi, B.S.; Lim, R.; Chang, H.K.; Chung, Y.H.; et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in sprague-dawley rats. Inhal. Toxicol. 2008, 20, 575-583. [Cross Ref] [Pub Med].
63. Kim, Y.S.; Song, M.Y.; Park, J.D.; Song, K.S.; Ryu, H.R.; Chung, Y.H.; Chang, H.K.; Lee, J.H.; Oh, K.H.; Kelman, B.J.; et al. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol. 2010, 7. [Cross Ref] [Pub Med].
64. Loeschner, K.; Hadrup, N.; Qvortrup, K.; Larsen, A.; Gao, X.Y.; Vogel, U.; Mortensen, A.; Lam, H.R.; Larsen, E.H. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part. Fibre Toxicol. 2011, 8. [Cross Ref] [Pub Med].
65. Van der Zande, M.; Vandebriel, R.J.; van Doren, E.; Kramer, E.; Rivera, Z.H.; Serrano-Rojero, C.S.; Gremmer, E.R.; Mast, J.; Peters, R.J.B.; Hollman, P.C.H.; et al. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012, 6, 7427-7442. [Cross Ref] [Pub Med].
66. Hadrup, N.; Loeschner, K.; Mortensen, A.; Sharma, A.K.; Qvortrup, K.; Larsen, E.H.; Lam, H.R. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology 2012, 33, 416-423. [Cross Ref] [Pub Med].
67. Cha, K.; Hong, H.W.; Choi, Y.G.; Lee, M.J.; Park, J.H.; Chae, H.K.; Ryu, G.; Myung, H. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol. Lett. 2008, 30, 1893-1899. [Cross Ref] [Pub Med].
68. Park, E.J.; Bae, E.; Yi, J.; Kim, Y.; Choi, K.; Lee, S.H.; Yoon, J.; Lee, B.C.; Park, K. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ. Toxicol. Pharmacol. 2010, 30, 162-168. [Cross Ref] [Pub Med].
69. Korani, M.; Rezayat, S.M.; Gilani, K.; Bidgoli, S.A.; Adeli, S. Acute and subchronic dermal toxicity of nanosilver in guinea pig. Int. J. Nanomed. 2011, 6, 855-862. [Cross Ref] [Pub Med].
70. Tang, J.L.; Xiong, L.; Wang, S.; Wang, J.Y.; Liu, L.; Li, J.A.; Wan, Z.Y.; Xi, T.F. Influence of silver nanoparticles on neurons and blood-brain barrier via subcutaneous injection in rats. Appl. Surf. Sci. 2008, 255, 502-504. [Cross Ref].
71. Tang, J.L.; Xiong, L.; Wang, S.; Wang, J.Y.; Liu, L.; Li, J.G.; Yuan, F.Q.; Xi, T.F. Distribution, translocation and accumulation of silver nanoparticles in rats. J. Nanosci. Nanotechnol. 2009, 9, 4924-4932. [Cross Ref] [Pub Med].